SEC Form 4 · accession 0001179110-18-004912
HEALTHEQUITY, INC. · HQY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ashley Dreier
Officer — Executive, VP, CTO and CIO
Period of report
Mar 27, 2018
Accepted (ET)
Mar 29, 2018 · 4:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001428336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 27, 2018 | A | 4,591 | $0.00 | A | 10,243 | D | |
| Common Stock | Mar 27, 2018 | F | 631 | $63.50 | D | 9,612 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2,F3 | $14.00 | Mar 27, 2018 | A | 3,000 | A | — | Jul 30, 2024 | Common Stock | 3,000 | 6,000 | D |
| Stock Option (right to buy)F3 | $1.50 | holding | — | — | — | — | May 9, 2023 | Common Stock | 16,750 | 16,750 | D |
| Stock Option (right to buy)F4 | $24.36 | holding | — | — | — | — | Mar 23, 2026 | Common Stock | 65,000 | 65,000 | D |
Explanation of responses
- F1Each restricted stock award represents a contingent right to receive one share of the issuer's common stock. The restricted stock awards vest as to 1,148 shares on March 27, 2019, 2020, and 2021, and as to 1,147 shares on March 27, 2022.
- F2On June 30, 2014, the reporting person was granted an option to purchase 10,000 shares of common stock. The option vests in annual installments based on the issuer's satisfaction of certain performance criteria for each of the fiscal years ending January 31, 2016 (10%), 2017 (20%), 2018 (30%) and 2019 (40%). The performance criteria for 2018 were met, resulting in the vesting of the option as to 3,000 shares.
- F3The option is immediately exercisable.
- F4The option is immediately exercisable as to 32,500 shares. The option becomes exercisable as to the remaining 32,500 shares in two equal installments on March 23, 2019 and 2020.